Verified Nov 2026
Electronics & Software
·
New York, New York
·
Since 2016
Synchron is a New York-based neurotechnology company founded in 2016 that develops implantable brain-computer interfaces. Its primary product, the Stentrode, is a motor neuroprosthesis delivered through the jugular vein by catheter rather than open-brain surgery, and clinical trials in the United States and Australia are assessing its use by people with paralysis. The company employs roughly 100 to 200 people, has estimated annual revenue of $50 to $100 million, is privately held, and serves the medical, electronics, and automotive sectors. In November 2025 it reported a $200 million Series D raise.
Synchron at a glance
Revenue
$50-100M
Est. band
Employees
100-200
Founded
2016
Headquarters
New York, New York
Certifications
ISO 9001
Industries
Automotive
Electric Vehicles
Electronics
Medical
Industrial Equipment
STABILITY SIGNALS
Established & active
10 years in operation (founded 2016).
Holds ISO 9001 certification(s) per public sources.
Overview
Synchron is a New York-based neurotechnology company founded in 2016 that develops implantable brain-computer interfaces. Its primary product, the Stentrode, is a motor neuroprosthesis delivered through the jugular vein by catheter rather than open-brain surgery, and clinical trials in the United States and Australia are assessing its use by people with paralysis. The company employs roughly 100 to 200 people, has estimated annual revenue of $50 to $100 million, is privately held, and serves the medical, electronics, and automotive sectors. In November 2025 it reported a $200 million Series D raise.
At a glance
Attribute | Detail |
|---|---|
Founded | 2016 |
Headquarters | New York, New York |
Employees | 100-200 |
Revenue | $50-100M (estimated) |
Primary capability | Electronics & Software |
Certifications | ISO 9001 |
What Synchron makes
The company holds ISO 9001 certification and develops catheter-delivered neural devices, including the Stentrode and endovascular neuromodulation technology for conditions such as Parkinson's disease, epilepsy, depression, and hypertension.
Certifications
Synchron is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 9001 — synchronlab.com
Latest developments
2026-04-27 — News — Synchron (synchron.com)
2026-04-18 — Synchron Moves BCI Toward Clinical Translation (neurofounders.co)
2026-01-05 — MIND CONTROL - San Diego Business Journal (sdbj.com)
2025-11-07 — NRFC invests AUD $54 million in Synchron’s groundbreaking brain-computer interface devices | National Reconstruction Fund Corporation (nrf.gov.au)
2025-11-06 — Synchron Raises $200 Million Series D to Advance Brain-Computer Interface Technology (businesswire.com)
2025-11-06 — Synchron raises $308m to leapfrog Neuralink, with $54m from NRF (forbes.com.au)
Facilities
Synchron is headquartered in New York, New York. Public sources also reference these locations:
New York — businesswire.com
Company details
Synchron is privately held and reports an employee band of 100 to 200, with its founders Thomas Oxley and Nicholas Opie having established the company in 2016. Synchron was founded in 2016, has an estimated 100-200 employees, and is headquartered in New York, New York. On the LightSource stability read it is rated "Established & active": 10 years in operation (founded 2016). Holds ISO 9001 certification(s) per public sources.
Frequently asked questions
What does Synchron make?
Synchron is a New York-based neurotechnology company founded in 2016 that develops implantable brain-computer interfaces. Its primary product, the Stentrode, is a motor neuroprosthesis delivered through the jugular vein by catheter rather than open-brain surgery, and clinical trials in the United States and Australia are assessing its use by people with paralysis. The company employs roughly 100 to 200 people, has estimated annual revenue of $50 to $100 million, is privately held, and serves the medical, electronics, and automotive sectors. In November 2025 it reported a $200 million Series D raise.
Where is Synchron headquartered?
Synchron is headquartered in New York, New York (63 Flushing Ave, New York, New York, 11205).
When was Synchron founded?
Synchron was founded in 2016.
How big is Synchron?
Synchron has an estimated 100-200 employees, with revenue in the $50-100M range (estimated).
What certifications does Synchron hold?
Synchron lists ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.